Inhibitors of human immunodeficiency virus replication
US9006235B2 · kind B2 · utility
7Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2013 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Mar 19, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/0812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.